Abstract
Copper transporter 1 (CTR1) is the primary high affinity importer for Cu(I) in eukaryotic cells. CTR1 plays an essential role in maintaining copper homeostasis which is crucial for diverse biological processes. Since its discovery in 1997, research on human CTR1 (hCTR1) has progressed from foundational biochemical characterization to detailed structural and functional elucidation, expanding our understanding of its involvement in human diseases. Here we summarize the current understanding of hCTR1, including its structural features, copper-binding motifs, regulation, trafficking pathways, and roles in disease. We also highlight emerging evidence implicating hCTR1 in cancer, neurodegenerative disorders, and inherited copper metabolism syndromes, emphasizing its potential as a therapeutic target and drug delivery facilitator. Finally, we discuss recent studies and outline future directions, aimed at fully harnessing the biomedical potential of hCTR1.
| Original language | English |
|---|---|
| Article number | 1739 |
| Journal | Biomolecules |
| Volume | 15 |
| Issue number | 12 |
| DOIs | |
| State | Published - 15 Dec 2025 |
Bibliographical note
Publisher Copyright:© 2025 by the authors.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cancer
- cisplatin uptake
- copper homeostasis
- human CTR1
- membrane transporter
- metalloprotein
- neurodegeneration
Fingerprint
Dive into the research topics of 'Human CTR1 Through the Ages: Milestones and Emerging Roles in Disease and Therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver